Prescribing Information | Safety Information | References

CARDURA XL Prescribing Information

To view Prescribing Information, you need Adobe^® Acrobat^® Reader^®.

Don't worry if you don't have it. It is FREE, and you can download Adobe^® Acrobat^® Reader^® here:

Already have Adobe^® Acrobat^® Reader^®?

View Prescribing Information

Don't have Adobe^® Acrobat^® Reader^®?

Download Adobe^® Acrobat^® Reader^® for FREE.

Note: When you click on the link above, you will leave the carduraxl.com Website. Links to other sites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

Important Safety Information

CARDURA XL is contraindicated in patients with a known sensitivity to other quinazolines (eg, prazosin, terazosin), doxazosin, or any of the inert ingredients. Postural hypotension with or without symptoms (eg, dizziness) may develop within a few hours following administration of CARDURA XL. However, infrequently, symptomatic postural hypotension has also been reported later than a few hours after dosing.

Caution should be used when administering CARDURA XL to patients with preexisting severe gastrointestinal tract narrowing, chronic constipation, or evidence of hepatic dysfunction.

The most commonly reported adverse events were: headache, dizziness, respiratory tract infection, asthenia, and back pain.

CA266876